On December 12, 2025, General Atlantic, a 10% owner of Alignment Healthcare, executed an open-market sale of 11,119,494 indirect shares valued at $206.5 million. This transaction reduced its indirect stake by 45.2%, leaving 13,476,585 shares with an estimated ownership value of $261 million. The shares traded at $18.57 each, a 4.1% discount to the $19.36 closing price, consistent with the firm’s systematic reduction pattern since September 2025. No direct holdings were affected; all activity occurred through affiliated entities, per the SEC Form 4 filing.

Alignment Healthcare reported third-quarter 2025 revenue of $993.7 million, up 43.5% year-over-year, and delivered membership growth of 31%, reaching approximately 275,300 as of January 1, 2026. The company exceeded the high end of its prior guidance for revenue and adjusted gross profit, while also raising full-year forecasts for membership, revenue, adjusted gross profit and adjusted EBITDA. Since its 2021 IPO, it has maintained a compounded annual membership growth rate near 30%, driven by its technology-enabled platform and expansion in California, North Carolina and Nevada.

Despite robust growth metrics, Centers for Medicare & Medicaid projections indicate Medicare Advantage enrollment will slip from 50% of the overall Medicare market in 2025 to approximately 48% in 2026. Alignment Healthcare projects year-end 2026 membership between 290,000 and 296,000, representing 24%–27% growth over the midpoint of its 2025 guidance. Consensus adjusted EBITDA for 2026 is expected near $145 million. Investors should weigh the company’s industry-leading membership gains against potential headwinds in the broader Medicare Advantage market and the recent insider selling by General Atlantic.